Vanda Pharmaceuticals Inc. (NASDAQ: VNDA)
$6.02
+0.1000 ( +1.69% ) 873.7K
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS), Fanapt for the treatment of schizophrenia and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from HETLIOZ product sales.
Market Data
Open
$6.02
Previous close
$5.92
Volume
873.7K
Market cap
$350.35M
Day range
$5.79 - $6.11
52 week range
$3.30 - $6.75
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Aug 23, 2023 |
8-k | 8K-related | 12 | Aug 21, 2023 |
4 | Insider transactions | 1 | Aug 11, 2023 |
4 | Insider transactions | 1 | Aug 01, 2023 |
10-q | Quarterly Reports | 75 | Jul 28, 2023 |
8-k | 8K-related | 14 | Jul 27, 2023 |